Lv1
30 积分 2024-07-23 加入
CD142 plays a key role in the carcinogenesis of gastric adenocarcinoma by inhibiting BCL2-dependent autophagy
12小时前
待确认
An in vitro pharmacodynamic spiking study of befovacimab, a tissue factor pathway inhibitor monoclonal antibody, in blood samples from patients with severe FVIII deficiency
23天前
已完结
Correction to: Concizumab: First Approval
23天前
已完结
Consistent clinical factor VIII equivalency is unlikely for non-factor therapies in hemophilic mice
25天前
已完结
Rapidly progressive pneumonitis days after receiving tisotumab vedotin: a new antibody–drug conjugate
25天前
已关闭
Abstract 739: AMT-253, a first-in-class MUC18-targeting antibody-drug conjugate, for the treatment of MUC18-positive solid tumors
29天前
已关闭
The target atlas for antibody-drug conjugates across solid cancers
1个月前
已完结
Intrinsic physicochemical profile of marketed antibody-based biotherapeutics
1个月前
已完结
180 (PB168): DB-1314, a novel DLL3-targeting ADC with DNA topoisomerase I inhibitor, exhibits promising therapeutic efficacy and safety profile in preclinical
3个月前
已完结
241P Development and characterization of a novel DLL3-targeting antibody drug conjugate (ADC) for the treatment of solid tumors
3个月前
已完结
皖公网安备34019202002308
